COVID-19: Bvlgari is the latest luxury brand to start making hand sanitisers
The hand gel sanitisers will be manufactured in Bvlgari's Lodi Factory, and distributed in priority to all medical facilities in Italy by the Italian Civil Protection Department.

Bvlgari is intensifying its support to Italian authorities in the fight against COVID-19 by producing hand sanitisers. (Art: Chern Ling)
Roman jeweller Bvlgari will join its LVMH peers in the manufacturing of hand-cleansing gels. The jeweller plans to manufacture “several hundreds of thousands of bottles” in the coming two months, produced together with Bvlgari’s longstanding fragrances partner, ICR.
READ> How LVMH went from making luxury perfumes to hand sanitisers in 72 hours
The sanitisers will be distributed in 75 ml recycled bottles to medical facilities in Italy by the Italian Civil Protection Department, in order to help the most critical infrastructures today waging war against the virus.
“I believe as a major economic actor and symbol of Italy, Bvlgari has a responsibility to contribute to the national effort to help prevent, fight and eradicate COVID-19,” said Jean-Christophe Babin, CEO of Bvlgari.
Babin added that the gels will be manufactured in Bvlgari’s Lodi Factory, which is already making high-end perfumes and hotel amenities.
“Aware of the difficult situation we are experiencing, we believe it is our duty to contribute with our know-how and production facilities, and we thank the Italian Civil Protection Department who will take care of the collection and distribution.”
“I believe as a major economic actor and symbol of Italy, Bvlgari has a responsibility to contribute to the national effort to help prevent, fight and eradicate COVID-19." – Jean-Christophe Babin
Bvlgari has been supporting the scientific and medical community in their fight against the coronavirus since the outbreak began. In early March, the jeweller donated an undisclosed sum to the research department of the Lazzaro Spallanzani Hospital in Rome to purchase a 3D microscope that will aid in the development of a vaccine against COVID-19.